Cargando…
Active removal of anterior segment-migrated dexamethasone implant (Ozurdex(®))
Background: Ozurdex(®) (Allergan plc., Dublin, Ireland) is an intravitreal sustained-release dexamethasone (DEX) implant. The implant has been reported to migrate into the anterior chamber, potentially causing corneal decompensation. Prompt removal or relocation in the vitreous cavity is advised but...
Autores principales: | Depla, Jozef Adelson M., Veckeneer, Marc, Bleyen, Isabel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
German Medical Science GMS Publishing House
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006423/ https://www.ncbi.nlm.nih.gov/pubmed/35465301 http://dx.doi.org/10.3205/oc000195 |
Ejemplares similares
-
The nomadic Ozurdex(®): Anterior migration of the dexamethasone implant and back!
por: Srinivasan, Priya, et al.
Publicado: (2017) -
Anterior Chamber Migration of Ozurdex Implants
por: Kayıkçıoğlu, Özcan, et al.
Publicado: (2020) -
Intravitreal Dexamethasone Implant (Ozurdex) in Coats’ Disease
por: Saatci, Ali Osman, et al.
Publicado: (2013) -
Fractured dexamethasone implant (OZURDEX®) following intravitreal injection
por: Aljohani, Saud M., et al.
Publicado: (2021) -
Splitting of a Dexamethasone Implant (Ozurdex) following the Injection
por: Donmez, Oya, et al.
Publicado: (2013)